Shares of LENSAR, Inc. (NASDAQ:LNSR – Get Free Report) shot up 2.3% during mid-day trading on Wednesday . The company traded as high as $5.84 and last traded at $5.84. Approximately 86,698 shares were traded during trading, a decline of 23% from the average session volume of 112,924 shares. The stock had previously closed at $5.71.
Analysts Set New Price Targets
A number of brokerages recently weighed in on LNSR. Weiss Ratings raised shares of LENSAR from a “sell (d-)” rating to a “sell (d+)” rating in a report on Monday, May 11th. Wall Street Zen lowered LENSAR from a “hold” rating to a “sell” rating in a research report on Saturday, May 16th. BTIG Research upgraded LENSAR from a “neutral” rating to a “buy” rating and set a $10.00 target price for the company in a research report on Tuesday, March 17th. Finally, Lake Street Capital upgraded LENSAR from a “hold” rating to a “buy” rating and set a $10.00 price target on the stock in a report on Wednesday, April 1st. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $10.00.
Check Out Our Latest Report on LNSR
LENSAR Stock Performance
LENSAR (NASDAQ:LNSR – Get Free Report) last released its quarterly earnings results on Friday, May 8th. The company reported $1.56 earnings per share for the quarter, beating the consensus estimate of $0.18 by $1.38. LENSAR had a net margin of 50.94% and a negative return on equity of 183.19%. The company had revenue of $13.43 million during the quarter, compared to analysts’ expectations of $13.40 million.
Hedge Funds Weigh In On LENSAR
Large investors have recently added to or reduced their stakes in the company. Geode Capital Management LLC boosted its position in LENSAR by 103.9% during the 2nd quarter. Geode Capital Management LLC now owns 219,373 shares of the company’s stock worth $2,890,000 after acquiring an additional 111,802 shares during the last quarter. Brandes Investment Partners LP grew its holdings in shares of LENSAR by 10.1% in the 4th quarter. Brandes Investment Partners LP now owns 856,216 shares of the company’s stock valued at $9,958,000 after acquiring an additional 78,513 shares in the last quarter. Evernest Financial Advisors LLC acquired a new stake in shares of LENSAR in the first quarter valued at about $393,000. Rangeley Capital LLC acquired a new stake in shares of LENSAR in the second quarter valued at about $658,000. Finally, Dynamic Technology Lab Private Ltd raised its holdings in LENSAR by 436.6% during the fourth quarter. Dynamic Technology Lab Private Ltd now owns 54,166 shares of the company’s stock worth $630,000 after acquiring an additional 44,072 shares in the last quarter. Institutional investors own 40.15% of the company’s stock.
LENSAR Company Profile
LENSAR, Inc, headquartered in Orlando, Florida, is a medical technology company specializing in advanced laser systems for ophthalmic surgery. Its flagship product, the LENSAR Laser System, combines proprietary three-dimensional imaging with precision-guided femtosecond laser delivery to perform critical steps in cataract procedures, including capsulotomy creation, lens fragmentation and corneal incisions.
Founded in 2005, LENSAR has concentrated its research and development efforts on enhancing surgical accuracy and patient outcomes in cataract treatment.
Read More
- Five stocks we like better than LENSAR
- AST SpaceMobile’s Japan Catalyst Puts Its Rollout Story Back in Focus
- Gold and Silver Recovery—3 Precious Metals Stocks for H2 2026
- Klarna’s Google Court Win Could Give Its BNPL Story a Needed Cash Catalyst
- Why Kroger’s Giant Eagle Deal Could Change Everything
Receive News & Ratings for LENSAR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LENSAR and related companies with MarketBeat.com's FREE daily email newsletter.
